Waters' Supercritical Fluid Extraction (SFE) systems extract chemical compounds using supercritical carbon dioxide instead of an organic solvent.
Waters' Supercritical Fluid Extraction (SFE) systems extract chemical compounds using supercritical carbon dioxide instead of an organic solvent. SFE allows you to extract compounds without altering the taste, aroma, or chemical composition of your product. SFE is an ideal tool for a range of applications in pharmaceutical, chemical, and food research laboratories, including flavor testing, desolvation within tablets, natural oil, herb, and spice extracts, decaffeination, and testing for contaminants, such as pesticides and herbicides. Manipulating the temperature and pressure of CO2 allows the material of interest to be selectively extracted. The result is an extract with superior purity and yield, and lower operating costs, as compared to traditional hydrocarbon-based solvent extraction systems. As a tunable solvent, CO2 is non-toxic, non-flammable, and physiologically compatible. This translates into a reduction in post–processing steps, clean–up and safety measurements. Additionally, because CO2 processing requires low temperatures, there is less deterioration of heat sensitive components in the extract. Choose from solvent–free pilot to lab–scale supercritical fluid extraction systems. Users can operate in a static, pressure control mode or a dynamic flow control mode. Options range from 100 mL up to 10 L. Models can include co–solvent pump, fractionation, and recycling. Learn More.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.